Home
DiseasesProductServiceEvents
Contact
Search
Sitemap
Bayer Links
Bayer Global
Bayer Animal Health
BayNews
Baytril Livestock
General Conditions of Use
Privacy Statement
Imprint

Product / Clinical Efficacy / Urinary Tract Infections / Clinical Use of Baytril    

Clinical Use of Baytril in UTI

Urinary tract infections are often difficult to treat, especially when the prostate is involved or when underlying primary disease complicates the condition.

Favourable antimicrobial properties and pharmacokinetics, as well as excellent renal tolerance make Baytril well suited to the treatment of UTI, even if prolonged treatment episodes are necessary to resolve chronically recurrent UTI and prostatitis.

PDF Version (Size: 839 KB)

References
(16) Hackmann F, Schierz G: Die Anwendung des Antiinfektivums Baytril in der Kleintierpraxis. Vet 10: 26-29, 1989.
(22) Murasugi E, Amamori T, Ishii S, Matsuo K, Watabe S, Hatekayama H, Sekiguchi N, Fukomoto K: Clinical efficacy of enrofloxacin in dogs and cats with urinary tract infection. Journal of Veterinary Medicine (Tokyo) 10: 801-806, 1995.
(23) Brondke D: Enrofloxacin ­ ein neues Antiinfektivum in der Veterinärmedizin ­ Einsatz bei Harnwegsinfektionen bei Hund und Katze. Kongressband DVG Tagung zu Gießen: 204-207, 1989.

   
Reported Efficacy of Baytril
Reported Efficacy of Baytril

Microscopic View
Microscopic View